HIV Screening Clinical Guidelines Implementation Guide
0.1.0 - CI Build Unknown region code '840'

HIV Screening Clinical Guidelines Implementation Guide, published by National Association of Community Health Centers, Inc. (NACHC). This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/cqframework/hiv-cds/ and changes regularly. See the Directory of published versions

: Tenofovir Alafenamide (TAF) 25 mg Order Codes - XML Representation

Draft as of 2024-08-12

Raw xml | Download



<ValueSet xmlns="http://hl7.org/fhir">
  <id value="nachc-g2-de18"/>
  <text>
    <status value="generated"/>
    <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: ValueSet nachc-g2-de18</b></p><a name="nachc-g2-de18"> </a><a name="hcnachc-g2-de18"> </a><a name="nachc-g2-de18-en-US"> </a><ul><li>Include these codes as defined in <a href="http://www.nlm.nih.gov/research/umls/rxnorm"><code>http://www.nlm.nih.gov/research/umls/rxnorm</code></a><table class="none"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>1741729</td><td>tenofovir alafenamide 25 MG</td></tr><tr><td>1858261</td><td>tenofovir alafenamide 25 MG Oral Tablet</td></tr><tr><td>1858263</td><td>tenofovir alafenamide 25 MG [Vemlidy]</td></tr><tr><td>1858267</td><td>tenofovir alafenamide 25 MG Oral Tablet [Vemlidy]</td></tr></table></li></ul></div>
  </text>
  <url value="http://fhir.org/guides/nachc/hiv-cds/ValueSet/nachc-g2-de18"/>
  <version value="0.1.0"/>
  <name value="TenofovirAlafenamideTAF25mgOrderCodes"/>
  <title value="Tenofovir Alafenamide (TAF) 25 mg Order Codes"/>
  <status value="draft"/>
  <experimental value="false"/>
  <date value="2024-08-12T19:50:21+00:00"/>
  <publisher
             value="National Association of Community Health Centers, Inc. (NACHC)"/>
  <contact>
    <telecom>
      <system value="url"/>
      <value value="https://www.nachc.org/"/>
    </telecom>
  </contact>
  <description
               value="Codes representing possible values for the Tenofovir Alafenamide (TAF) 25 mg Order element"/>
  <jurisdiction>
    <coding>
      <system value="http://unstats.un.org/unsd/methods/m49/m49.htm"/>
      <code value="840"/>
    </coding>
  </jurisdiction>
  <immutable value="true"/>
  <copyright
             value="Copyright National Association of Community Health Centers, Inc. (NACHC)"/>
  <compose>
    <include>
      <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
      <concept>
        <code value="1741729"/>
        <display value="tenofovir alafenamide 25 MG"/>
      </concept>
      <concept>
        <code value="1858261"/>
        <display value="tenofovir alafenamide 25 MG Oral Tablet"/>
      </concept>
      <concept>
        <code value="1858263"/>
        <display value="tenofovir alafenamide 25 MG [Vemlidy]"/>
      </concept>
      <concept>
        <code value="1858267"/>
        <display value="tenofovir alafenamide 25 MG Oral Tablet [Vemlidy]"/>
      </concept>
    </include>
  </compose>
</ValueSet>